AACAP Logo

Login  |  Help  |  About Us
2009 Psychopharmacology Update Institute
Faculty

Gabrielle A. Carlson, M.D., Chair
Professor of Psychiatry and Pediatrics
Director, Child and Adolescent Psychiatry
Stony Brook University School of Medicine
Stony Brook, NY
Disclosures
Advisor/Consultant: Bristol-Meyers Squibb Company, Eli Lilly and Company, Otsuka America Pharmaceutical, Inc.
Honorarium & Travel Expenses: American Academy of Child & Adolescent Psychiatry
Research Funding: Bristol-Meyers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Otsuka America Pharmaceutical, Inc.
Spouse Advisor/Consultant: H. Lundbeck A/S

Laurence L. Greenhill, M.D.
Ruane Professor of Clinical Psychiatry
Columbia University Research
Psychiatrist II
Director, Research Unit of Pediatric Psychopharmacology - Psychosocial Intervention
New York State Psychiatric Institute
New York, NY
Disclosures
Advisor/Consultant: McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., Pfizer, Inc.
Honorarium & Travel Expenses: American Academy of Child & Adolescent Psychiatry
Research Funding: Forest Laboratories, Inc., Johnson & Johnson, Otsuka America Pharmaceutical, Inc.

Boris Birmaher, M.D.
Endowed Chair in Early Onset Bipolar Disease
Professor of Psychiatry
University of Pittsburgh School of Medicine
Western Psychiatric Institute and Clinic University of Pittsburgh Medical Center
Pittsburgh, PA
Disclosures
Book: New Hope for Children & Teens with Bipolar Disorder: Random House, Inc.
Honoraria for participating in forums: ABcomm, Inc., Jazz Pharmaceuticals, Inc., Solvay Pharmaceuticals
Honorarium & Travel Expenses: American Academy of Child & Adolescent Psychiatry
Research Funding: National Institute of Mental Health

Matthew State, M.D., Ph.D.
Donald J. Cohen Associate Professor
Yale Child Study Center
Associate Professor of Genetics and Co-Director, Program on Neurogenetics
Yale University School of Medicine
New Haven, CT
Disclosures
Honorarium & Travel Expenses: American Academy of Child & Adolescent Psychiatry

Harold E. Carlson, M.D.
Professor of Medicine
Division Head, Endocrinology and Metabolism
Stony Brook University
Stony Brook, NY
Disclosures
Advisor/Consultant: H. Lundbeck A/S
Honorarium & Travel Expenses: American Academy of Child & Adolescent Psychiatry
Spouse Advisor/Consultant: Bristol- Meyers Squibb Company, Eli Lilly and Company, Otsuka America Pharmaceutical, Inc.
Spouse Research Funding: Bristol- Meyers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Otsuka America Pharmaceutical, Inc.

John T. Walkup, M.D.
Associate Professor, Department of Psychiatry and Behavioral Sciences
Johns Hopkins Medical Institutions
Johns Hopkins University School of Medicine
Baltimore, MD
Disclosures
Advisor/Consultant: Cliff's Communities, GlaxoSmithKline, Tourette Syndrome Association
Honorarium & Travel Expenses: American Academy of Child & Adolescent Psychiatry
Other: Abbott Laboratories (free drug), Eli Lilly and Company (free drug and placebo), Pfizer, Inc. (free drug and placebo)
Speaker's Bureau: Tourette Syndrome Association

Barbara J. Coffey, M.D., M.S.
Associate Professor, Department of Psychiatry
NYU School of Medicine
Director, Institute for Tourette and Tic Disorders
NYU Child Study Center
New York, NY
Disclosures
Advisor/Consultant: Eli Lilly and Company, Jazz Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Tourette Syndrome Association
Honorarium & Travel Expenses: American Academy of Child & Adolescent Psychiatry
Research Funding: Boehringer Ingelheim, Bristol-Meyers Squibb Company, Eli Lilly and Company, National Institute of Neurological Disorders and Stroke/National Institutes of Health, Tourette Syndrome Association
Speaker's Bureau: Tourette Syndrome Association

Christoph U. Correll, M.D.
Associate Professor of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Medical Director, Recognition and Prevention Program
The Zucker Hillside Hospital
Glen Oaks, NY
Disclosures
Advisor/Consultant: AstraZeneca Pharmaceuticals, LP, Bristol-Meyers Squibb Company, Eli Lilly and Company, Intra-Cellular Therapies, Organon, Inc., Otsuka America Pharmaceutical, Inc., Pfizer, Inc., Solvay Pharmaceuticals, Supernus Pharmaceuticals, Inc., Vanda Pharmaceuticals
Data Safety Monitoring Board: Bristol-Meyers Squibb Company, Supernus Pharmaceuticals, Otsuka America Pharmaceutical, Inc.
Honorarium & Travel Expenses: American Academy of Child & Adolescent Psychiatry
Speaker's Bureau: AstraZeneca Pharmaceuticals, LP, Bristol-Meyers Squibb Company, Otsuka America Pharmaceutical, Inc.

AACAP Institutes Subcommittee
Melissa P. DelBello, M.D., Chair
Laurence L. Greenhill, M.D.
Bennett L. Leventhal, M.D.
Joan L. Luby, M.D.
Neal D. Ryan, M.D.
Timothy Wilens, M.D.

DISCLOSURE STATEMENT
Before the program, all faculty members will disclose the existence of any financial interests and/or other relationships (e.g. consultant, speakers bureau, grant recipient, research support, stock ownership) they may have with a) the manufacturers of any commercial products to be discussed during their presentation and/or b) any commercial contributor to this activity. When unlabeled uses are discussed, these will also be indicated.